Panacea Biotec Ltd. — Regulatory Filings 2021

Apr 29, 2021

==> picture [142 x 65] intentionally omitted <==

April 29, 2021

Mr. Sareesh Koroth, Chief Manager Surveillance, The National Stock Exchange of India Ltd., Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai - 400 051 NSE Symbol : PANACEABIO

Sub.: Clarification on Movement in Price

Ref.: Letter No. NSE/CM/Surveillance/10618 dated April 28, 2021

Dear Sir,

With reference to the captioned subject, we would like to state as under:

1. The Company has made all the necessary disclosures pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 from time to time and has not withheld any material information/ announcement that in our opinion would have a bearing on the price / volume behavior in the scrip.

2. As on date, there are no pending information/ announcement (including impending announcement) which in our opinion may have a bearing on the price / volume behavior in the scrip.

You are requested to take the same on records.

Thanking you, Sincerely yours,

For Panacea Biotec Ltd.

==> picture [123 x 38] intentionally omitted <==

Vinod Goel Group CFO and Head Legal & Company Secretary

Panacea Biotec Ltd (CIN: L33117PB1984PLC022350) Regd. Office : Ambala Chandigarh Higway, Lalru – 140501, Punjab Correspondence/Corporate office : B-1 Extn../G-3, Mohan Co-op. Indl. Estate, Mathura Road, New Delhi - 110 044, India Ph.: 91-11-4167 9000, 4167 8000, Fax: 91-11-4167 9070 Email: companysec@panaceabiotec.com